ELOCP18

Across TCGA pan-cancer cohorts, ELOCP18 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated ELOCP18 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ELOCP18 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ELOCP18 expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

ACC, LGG, and COAD are the cancer types where ELOCP18 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	IV	0.271	0.631	.002	48	view →
LGG	OS	Tertile	All	0.731	0.848	<.001	37	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
LAML	DFS	Tertile	All	0.203	0.418	.047	24	view →
KIRC	DFS	Tertile	IV	0.221	0.603	.046	18	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	18	view →
READ	DFS	Tertile	IV	0.082	0.618	.012	18	view →
THCA	DFS	Tertile	III,IV	0.149	0.701	.039	18	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	9	view →
OV	OS	Tertile	IV	0.862	0.698	.038	4	view →
HNSC	OS	Tertile	III,IV	0.481	0.708	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

ELOCP18–ACC (OS)

Open the ACC breakdown →